The appointment of a former lobbyist to such an important job “bodes very poorly for what we are about to see from the next Trump administration,” said Craig Holman, himself a registered lobbyist for ...
Investing in biotechnology stocks has always required a high risk tolerance and the patience to wait years, even decades, for results. Uneven results in recent years, and in the year to date ...
Take the most important step in your career: help us change the lives of people, families and communities for the better. Communiqué de presse - Sanofi renforce la bioproduction d’anticorps en France ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug development for Parkinson’s disease. GSK will pay $80 million ...
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat amyotrophic lateral sclerosis with a new strategy. Trace Neuroscience ...
Third Rock Ventures, the well-known backer of biotechnology companies, is leading a nine-figure fundraising round for a startup that aims to treat ALS by replacing broken genetic machinery. The ...
Is less regulation by the Food and Drug Administration good for the biotech industry? Do vaccine makers like Pfizer have a target on their back now? And will the “Make America Healthy Again ...
“We have to hope that this administration, and every administration, appoints people who are familiar with the science in an apolitical manner.” While biotech leaders may view Kennedy with some ...